United States Department of Veterans Affairs
Glenn W. Kaatz spends much of his time researching Staphylococcus aureus, Microbiology, Efflux, Antibacterial agent and Multiple drug resistance. His Staphylococcus aureus research is multidisciplinary, incorporating perspectives in Norfloxacin, Antimicrobial and Antibiotics. Glenn W. Kaatz interconnects Methicillin-resistant Staphylococcus aureus and SCCmec in the investigation of issues within Microbiology.
He has included themes like Clindamycin, Leukocidin, Teicoplanin and Linezolid in his SCCmec study. His Efflux research includes themes of Ethidium bromide, Ciprofloxacin, Bacteria and Pharmacology. He studies Vancomycin, focusing on Daptomycin in particular.
Glenn W. Kaatz mainly focuses on Microbiology, Staphylococcus aureus, Efflux, Antibacterial agent and Pharmacology. His study looks at the relationship between Microbiology and topics such as Methicillin-resistant Staphylococcus aureus, which overlap with Clindamycin. His research integrates issues of Antibiotics, Antimicrobial and Drug resistance in his study of Staphylococcus aureus.
His Efflux research is multidisciplinary, relying on both Ethidium bromide, Multiple drug resistance and Antibiotic resistance, Bacteria. His study in Antibacterial agent is interdisciplinary in nature, drawing from both Rifampicin, Norfloxacin, Enterococcus faecalis, Staphylococcus and Streptococcus pyogenes. The various areas that Glenn W. Kaatz examines in his Vancomycin study include Glycopeptide, Lipopeptide and SCCmec.
His main research concerns Efflux, Staphylococcus aureus, Microbiology, Pharmacology and Multiple drug resistance. The study incorporates disciplines such as Antibacterial activity, Bacteria, Gene and Benzothiazine in addition to Efflux. His Staphylococcus aureus research is multidisciplinary, incorporating elements of In vitro, Antibiotics, Antibiotic resistance, Antimicrobial and Ethidium bromide.
His work carried out in the field of Microbiology brings together such families of science as Vancomycin and Daptomycin. The concepts of his Vancomycin study are interwoven with issues in Methicillin-resistant Staphylococcus aureus, Cephalosporin, Pharmacodynamics, Penicillin binding proteins and Lipopeptide. His work in Pharmacology addresses issues such as Ciprofloxacin, which are connected to fields such as Quantitative structure–activity relationship and Structure–activity relationship.
Staphylococcus aureus, Microbiology, Efflux, Multiple drug resistance and Vancomycin are his primary areas of study. His research on Staphylococcus aureus frequently links to adjacent areas such as Antimicrobial. His work in Microbiology covers topics such as In vitro which are related to areas like Glycopeptide, Daptomycin and Lysostaphin.
His Efflux study integrates concerns from other disciplines, such as Antibacterial activity, Structure–activity relationship, Antibacterial agent and Drug resistance. His Multiple drug resistance study combines topics from a wide range of disciplines, such as Ethidium bromide and Pharmacology. Glenn W. Kaatz combines subjects such as Synthetic derivatives and Antibiotics with his study of Pharmacology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Antibacterial and resistance modifying activity of Rosmarinus officinalis
Moyosoluwa Oluwatuyi;Glenn W. Kaatz;Simon Gibbons.
Efflux-Related Resistance to Norfloxacin, Dyes, and Biocides in Bloodstream Isolates of Staphylococcus aureus
Carmen E. DeMarco;Laurel A. Cushing;Emmanuel Frempong-Manso;Susan M. Seo.
Antimicrobial Agents and Chemotherapy (2007)
A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus
Simon Gibbons;Moyosoluwa Oluwatuyi;Glenn W. Kaatz.
Journal of Antimicrobial Chemotherapy (2003)
Antibacterials and modulators of bacterial resistance from the immature cones of Chamaecyparis lawsoniana
Eileen C.J. Smith;Elizabeth M. Williamson;Neale Wareham;Glenn W. Kaatz.
Multidrug efflux pump overexpression in Staphylococcus aureus after single and multiple in vitro exposures to biocides and dyes
Aurélie A. Huet;Aurélie A. Huet;Jose L. Raygada;Kabir Mendiratta;Susan M. Seo.
Community- and health care-associated methicillin-resistant Staphylococcus aureus: a comparison of molecular epidemiology and antimicrobial activities of various agents.
Brian T. Tsuji;Brian T. Tsuji;Brian T. Tsuji;Michael J. Rybak;Michael J. Rybak;Michael J. Rybak;Chrissy M. Cheung;Muhammad Amjad;Muhammad Amjad.
Diagnostic Microbiology and Infectious Disease (2007)
From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump.
Stefano Sabatini;Glenn W. Kaatz;Gian Maria Rossolini;David Brandini.
Journal of Medicinal Chemistry (2008)
Characteristics of Patients With Healthcare‐Associated Infection Due to SCCmec Type IV Methicillin‐Resistant Staphylococcus aureus
Susan L. Davis;Michael J. Rybak;Muhammad Amjad;Glenn W. Kaatz.
Infection Control and Hospital Epidemiology (2006)
Catechin gallates inhibit multidrug resistance (MDR) in Staphylococcus aureus.
Simon Gibbons;Elisabeth Moser;Glenn W. Kaatz.
Planta Medica (2004)
Polyacylated Oligosaccharides from Medicinal Mexican Morning Glory Species as Antibacterials and Inhibitors of Multidrug Resistance in Staphylococcus aureus
Rogelio Pereda-Miranda;Glenn W. Kaatz;Simon Gibbons.
Journal of Natural Products (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: